---
title: "Roche Pharmaceuticals rents a property in Central Plaza, Wan Chai for a monthly rent of HKD 405,000"
description: "Swiss multinational Roche recently leased a unit with an area of approximately 9,000 square feet in the Central Plaza in Wan Chai, with a monthly rent of about HKD 405,000, and a rent per square foot "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/247057272.md"
published_at: "2025-07-03T01:25:41.000Z"
---

# Roche Pharmaceuticals rents a property in Central Plaza, Wan Chai for a monthly rent of HKD 405,000

> Swiss multinational Roche recently leased a unit with an area of approximately 9,000 square feet in the Central Plaza in Wan Chai, with a monthly rent of about HKD 405,000, and a rent per square foot of about HKD 45, which is at market level. Roche has changed office locations multiple times since 2011, and this time it is returning to the Hong Kong Island area. Although the leased area has decreased, it is expected to save on rental expenses, representing an upgrade move

According to comprehensive media reports, Swiss multinational company Roche recently leased a unit with an area of approximately 9,000 square feet on a mid-low floor of Central Plaza in Wan Chai, with a monthly rent of about HKD 405,000 and a rent per square foot of about HKD 45, which is at market level.

According to records, Roche has changed office locations multiple times since 2011. The company previously rented the entire floor of Lee Garden Three in Causeway Bay in 2011, with an area of 15,000 square feet, and later moved to East Kowloon, leasing the entire floor of the Chow Tai Fook Insurance Centre in Kowloon Bay, expanding the floor area to 16,000 square feet. This time returning to the Hong Kong Island area, although the leased floor area has decreased, it is expected to save on rental expenses, representing an upgrade relocation

### Related Stocks

- [RHHBY.US - Roche](https://longbridge.com/en/quote/RHHBY.US.md)
- [01929.HK - CHOW TAI FOOK](https://longbridge.com/en/quote/01929.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 惠誉在更新公司评级标准后维持了对 Hikma 和罗氏的评级 | 惠誉在更新企业评级标准后维持对 Hikma 和罗氏 (ADR) 的评级 | [Link](https://longbridge.com/en/news/275874477.md) |
| 罗氏公司称，实验性药物在进行性多发性硬化症研究中有助于减缓残疾的进展 | 罗氏的口服药物芬布利单抗在三期临床试验中显示出减缓原发性进行性多发性硬化症（PPMS）患者残疾进展的潜力。该药物相比于 Ocrevus（目前唯一批准用于 PPMS 的治疗药物）显示出 12% 的残疾进展风险降低。这一突破可能为 PPMS 患 | [Link](https://longbridge.com/en/news/275319325.md) |
| 期权热点｜上周五 NBIS 大涨 9%，部分看涨期权飙升 378% | 美东时间 02 月 13 日，Nebius 期权总成交 179098 张，看涨期权占比 71%，看跌期权占比 28%。 | [Link](https://longbridge.com/en/news/276030151.md) |
| 期权热点｜上周五 MARA 大涨 9%，部分看涨期权飙升 100% | 美东时间 02 月 13 日，Marathon Digital 期权总成交 306843 张，看涨期权占比 67%，看跌期权占比 32%。 | [Link](https://longbridge.com/en/news/276030109.md) |
| 期权热点｜上周五 IREN 大涨 5%，部分看涨期权飙升 400% | 美东时间 02 月 13 日，IREN 期权总成交 270906 张，看涨期权占比 50%，看跌期权占比 49%。 | [Link](https://longbridge.com/en/news/276030070.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.